Where Will Tyme Technologies Inc (TYME) Stock Go Next After It Has Fallen 0.00% in a Week?

Thursday, June 30, 2022 11:09 AM | InvestorsObserver Analysts

Mentioned in this article

Where Will Tyme Technologies Inc (TYME) Stock Go Next After It Has Fallen 0.00% in a Week?

Overall market sentiment has been high on Tyme Technologies Inc (TYME) stock lately. TYME receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Tyme Technologies Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on TYME!

See Full TYME Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With TYME Stock Today?

Tyme Technologies Inc (TYME) stock is trading at $0.28 as of 10:58 AM on Thursday, Jun 30, a gain of $0.01, or 2.62% from the previous closing price of $0.28. The stock has traded between $0.26 and $0.30 so far today. Volume today is below average. So far 150,829 shares have traded compared to average volume of 670,039 shares. To see InvestorsObserver's Sentiment Score for Tyme Technologies Inc click here.

More About Tyme Technologies Inc

Tyme Technologies Inc is the U.S based clinical-stage biotechnology company. The company is focused on the development and commercialization of targeted cancer therapeutics with a broad range of oncology indications for humans. SM 88, its proprietary drug candidate compound, is a novel compound that has the potential to alter defenses to oxidative stress and increase free radical availability to the cancer cell. The company is currently conducting a Phase II trial in prostate cancer. Click Here to get the full Stock Report for Tyme Technologies Inc stock.